英文別名: |
Pimozide;1-[1-[4,4-Bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one;3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one;McN-JR-6238;Neoperidole;Opiran;Orap;pimozida;Pimozidum;R6238;1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one;PIMOZIDE [EP MONOGRAPH];NCGC00015802-03;SW196639-3;KBio3_002441;HMS3370N13;Pimozide, United States Pharmacopeia (USP) Reference Standard;Primozida [INN-Spanish];NCGC00024888-02;5-24-02-00367 (Beilstein Handbook Reference);SDCCGSBI-0050920.P004;Tox21_500946;NS00003971;NCGC00261631-01;HMS3411J16;MFCD00055081;N-benzyl-N-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)benzenamine;LP00946;NSC757854;SR-01000075392-4;PIMOZIDE (USP-RS);1-[1-[4,4-Bis(p-flurophenyl)butyl]-4-piperidyl]-2-benzimidazolinone;PIMOZIDE (MART.);pimozide;PIMOZIDE (USP MONOGRAPH);HY-12987;PIMOZIDE [INN];Prestwick3_000308;CCG-36461;AB00052215_07;2062-78-4;1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one;R 623;SR-01000075392-1;NINDS_000386;PIMOZIDE [USAN];NCGC00015802-14;NSC 170984;MLS001077311;IDI1_000386;NCGC00016601-01;Spectrum3_001451;HMS2089C11;Prestwick1_000308;BRD-K01292756-001-06-0;HMS1921H19;2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-;2-Benzimidazolinone, 1-[1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-;NCGC00015802-10;NSC170984;1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone;NCGC00015802-29;Orap (TN);KBioGR_000720;NCGC00015802-26;NCGC00015802-13;SR-01000075392-3;Tox21_301586;DivK1c_000386;R-623;Prestwick2_000308;1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one;HMS3712N18;BPBio1_000304;HMS1568N18;Pharmakon1600-01501134;NCGC00015802-01;Pimozidum [INN-Latin];P 1793;McN-JR 6238;NCGC00024888-04;NCGC00015802-18;Primozide;Spectrum5_001308;SPBio_001211;Q144085;Lopac0_000946;C07566;CCG-35918;AB00052215;Pimozide [USAN:USP:INN:BAN:JAN];FT-0673903;2-Benzimidazolinone,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-;Spectrum4_000420;1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one;NCGC00015802-16;Spectrum2_001026;HMS2095N18;EINECS 218-171-7;R-6238;3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one;HMS3262N14;CS-0012921;N05AG02;PIMOZIDE [USP-RS];NCGC00015802-08;BCBcMAP01_000043;AKOS024458706;KBio2_006061;1-(1-(4,4-Bis(4-fluorophenyl)butyl)piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one;Opera_ID_1580;HMS2231P23;CHEMBL1423;EU-0100946;Tox21_110224;Pimozide (JP17/USP/INN);Pimozida [INN-Spanish];AS-13916;UNII-1HIZ4DL86F;DTXSID8023474;NCGC00024888-06;F70142;CCG-39728;2H-Benzimidazol-2-one,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-;MLS002702058;AB00052215_08;BSPBio_000276;L000494;HMS1989H21;SPBio_002495;MLS000028410;R 6238;NCGC00015802-12;CAS-2062-78-4;NCGC00015802-02;1-(1-(4,4-BIS(... |